Gene · 4605
Papers2,561
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 2,561
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| MYBL2 is a Novel Independent Prognostic Biomarker and Correlated with TMB in pancreatic cancer. | J Cancer | 2024 | 38947375 | PubTator, text mining | PubMed |
| DEPDC1B is a Novel Direct Target of B-Myb and Contributes to Malignant Progression and Immune Infiltration in Lung Adenocarcinoma. | Front Biosci (Landmark Ed) | 2024 | 38940035 | PubTator, text mining | PubMed |
| Alteration of Gene Expression in Pathological Keratinization of the Ocular Surface. | Invest Ophthalmol Vis Sci | 2024 | 38935029 | PubTator, text mining | PubMed |
| The role of NCAPH in cancer treatment. | Cell Signal | 2024 | 38901722 | PubTator, text mining | PubMed |
| Emerging role of MYB transcription factors in cancer drug resistance. | Cancer Drug Resist | 2024 | 38835346 | PubTator, text mining | PubMed |
| CircMYBL2 facilitates hepatocellular carcinoma progression by regulating E2F1 expression. | Oncol Res | 2024 | 38827325 | PubTator, text mining | PubMed |
| The p21CIP1-CDK4-DREAM axis is a master regulator of genotoxic stress-induced cellular senescence. | Nucleic Acids Res | 2024 | 38783095 | PubTator, text mining | PubMed |
| Contribution of CENP-F to FOXM1-Mediated Discordant Centromere and Kinetochore Transcriptional Regulation. | Mol Cell Biol | 2024 | 38779933 | PubTator, text mining | PubMed |
| A-MYB substitutes for B-MYB in activating cell cycle genes and in stimulating proliferation. | Nucleic Acids Res | 2024 | 38747345 | PubTator, text mining | PubMed |
| G-quadruplex forming motifs in the promoter region of the B-MYB proto-oncogene. | Int J Biol Macromol | 2024 | 38729459 | PubTator, text mining | PubMed |
| Changes in the Transcription of Proliferation- and Apoptosis-Related Genes in Embryos in Women of Different Ages under the Influence of Extracellular Vesicles from Donor Follicular Fluid In Vitro. | Bull Exp Biol Med | 2024 | 38727955 | PubTator, text mining | PubMed |
| Construction and verification of an endoplasmic reticulum stress-related prognostic model for endometrial cancer based on WGCNA and machine learning algorithms. | Front Oncol | 2024 | 38725627 | PubTator, text mining | PubMed |
| Identification of master regulator genes controlling pathogenic CD4+ T cell fate in inflammatory bowel disease through transcriptional network analysis. | Sci Rep | 2024 | 38719901 | PubTator, text mining | PubMed |
| Unveiling the Biocontrol Potential of Rhizoplane Bacillus Species against Sugarcane Fusarium Wilt through Biochemical and Molecular Analysis. | Braz J Microbiol | 2024 | 38609692 | PubTator, text mining | PubMed |
| A Mettl16/m6A/mybl2b/Igf2bp1 axis ensures cell cycle progression of embryonic hematopoietic stem and progenitor cells. | EMBO J | 2024 | 38605226 | PubTator, text mining | PubMed |
| Identification of PANoptosis-related predictors for prognosis and tumor microenvironment by multiomics analysis in glioma. | J Cancer | 2024 | 38577605 | PubTator, text mining | PubMed |
| B-Myb deficiency boosts bortezomib-induced immunogenic cell death in colorectal cancer. | Sci Rep | 2024 | 38565963 | PubTator, text mining | PubMed |
| Targeting proto-oncogene B-MYB G-quadruplex with a nucleic acid-based fluorescent probe. | Int J Biol Macromol | 2024 | 38522681 | PubTator, text mining | PubMed |
| The oncogene MYBL2 promotes the malignant phenotype and suppresses apoptosis through hedgehog signaling pathway in clear cell renal cell carcinoma. | Heliyon | 2024 | 38510035 | PubTator, text mining | PubMed |
| RNA m5C modification upregulates E2F1 expression in a manner dependent on YBX1 phase separation and promotes tumor progression in ovarian cancer. | Exp Mol Med | 2024 | 38424195 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4605/papers?page=8